Last checked at 3 May 2024 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades16,417
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,050.00
Bid:
12,038.00
Ask:
12,040.00
Change:
-106.00 (-0.87%)
Spread:
2.00 (0.017%)
Open:
12,092.00
High:
12,178.00
Low:
12,010.00
Prev. Close:
12,156.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.London pre-open: Flat start predicted for FTSE
Mon, 29th Sep 2014 07:42
London's blue chips are set to open flat on Monday morning ahead of a very busy week both at home and abroad, particularly in the latter half. City sources predict the FTSE 100 will open unchanged from Friday's close of 6,649."European markets are set for an incredibly busy week as we see the first week of the new month," said Alpari market analyst James Hughes.He continued: "The story overnight is yet again the strength of the US dollar as Asian markets fell led by a thrashing in Hong Kong [...] However, if anything is going to shift investor opinion about the dollar it could well be this week as the data is incredibly heavy."This afternoon we will get the release of the personal consumption numbers as well as pending home sales figures. Investors will be yet again looking for any kind of positive number that could force Janet Yellen's hand into an earlier rate hike." In company news, emerging markets focused asset manager Aberdeen saw assets under management (AuM) rise by 3% in the two months to 31 August, as the rate of net outflows moderated considerably. Net outflows over the last two months amounted to just £1.7bn, after a drain of £8.8bn in the two months prior. The largest decrease in AuM was seen at Aberdeen's fixed income unit. Executives at the fund manager also highlighted that the integration of Scottish Widows Investment Partnership (SWIP) was progressing as scheduled.Despite the on-going, yet limited, disruptions to trading as a result of the 'sequestration' of US federal government expenditure, defence contractor BAE Systems maintained its full-year earnings outlook. In its latest interim management statement for the three months ended 28 September, the group revealed that its order intake for the year to 23 August was at £7.9bn, with £2.6bn of that originating from non-UK/US markets.Astrazeneca has presented data relating to various cancer treatment studies at the 2014 European Society of Medical Oncology Congress. "We are encouraged by the results we are seeing and look forward to providing further updates as we continue to work at pace to get these potentially life-changing medicines to patients," the drugs group said.
More News
3 May 2024 11:50
Angle shares up on assay development deal with AstraZenaca
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.
Read more3 May 2024 07:50
LONDON BRIEFING: InterContinental Hotels makes first-quarter progress
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.
Read more2 May 2024 10:04
AstraZeneca notes positive trial results for Calquence treatment
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.
Read more2 May 2024 07:45
AstraZeneca reports positive results from blood cancer drug trial
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.
Read more29 Apr 2024 22:52
J&J, Bristol Myers lose challenges to US drug price negotiation program
April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.
Read more29 Apr 2024 10:02
LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more29 Apr 2024 09:13
AstraZeneca makes progress with Truqap and Enhertu cancer treatments
(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.
Read more29 Apr 2024 07:50
LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid
(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.
Read more29 Apr 2024 07:24
AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Read more26 Apr 2024 09:33
LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:
Read more25 Apr 2024 16:57
LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge
(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.
Read more25 Apr 2024 15:14
London close: Stocks finish mixed as US GDP growth slows
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Read more25 Apr 2024 11:50
LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American
(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.
Read more25 Apr 2024 10:33